AAPS Journal Flags Underrated Skin Risks of COVID Vaccines, Citing Systemic Health Concerns
Event summary
- The Journal of American Physicians and Surgeons published an article on March 10, 2026, highlighting underreported skin-related adverse effects of COVID-19 vaccines.
- Dr. Jane M. Orient argues that skin pathologies are critical indicators of systemic health issues, including autoimmune conditions, and have been overlooked by regulators.
- The article cites the mRNA vaccine platform's use of lipid nanoparticles and polyethylene glycol as potential new harmful mechanisms.
- Global pharmacovigilance databases like the AAD COVID-19 Registry and ILDS have documented cutaneous side effects, but concerns have been dismissed by officials.
The big picture
The article underscores a growing tension between emerging evidence of vaccine-related health risks and regulatory oversight. As mRNA vaccine platforms continue to evolve, the debate over their safety profiles could intensify, particularly if more systemic health concerns are linked to cutaneous reactions. The broader implications for public health and vaccine hesitancy remain significant, with potential impacts on future vaccination campaigns and regulatory policies.
What we're watching
- Regulatory Response
- Whether health regulators will revisit the risk/benefit profiles of mRNA vaccines in light of new evidence on cutaneous and systemic adverse effects.
- Physician Awareness
- The extent to which physicians will prioritize diagnostic due diligence for cutaneous signs in vaccinated patients, as recommended by Dr. Orient.
- Public Perception
- How the public's awareness and acceptance of COVID-19 vaccines may shift in response to growing evidence of underreported adverse effects.
Related topics